×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [copiesml slide]
Home >
copiesml slide
HIV Therapy Failure Pr Christine Katlama Hopital Pitié Salpérière EACS Advanced Course Sept 2010 SOLTHIS.
216 views
Welcome to I-TECH HIV/AIDS Clinical Seminar Series HIV and the Nervous System, Part 3 Christina M. Marra, MD June 18, 2009.
213 views
Switching from first ART regimen while virologically suppressed is common in the CANOC cohort and is associated with increased risk of subsequent virologic.
216 views
Hepatitis web study Hepatitis web study Peginterferon alfa-2a versus Interferon alfa-2a Phase 3 Treatment Naïve, Chronic HCV Zeuzem S, et al. N Engl J.
218 views
Demonstrating that an HIV Vaccine Lowers the Risk and/or Severity of HIV infection D.Mehrotra 1*, X.Li 1, P.Gilbert 2 1 Merck Research Laboratories, Blue.
213 views
Clinical Significance of HIV-1 Drug Resistance Daniel R. Kuritzkes, MD Section of Retroviral Therapeutics Brigham and Women’s Hospital Harvard Medical.
214 views
MRC Unit, The Gambia Leading scientific research to save lives and improve health across the developing world DNA methylation as an epigenetic marker in.
213 views
Benefits and Risks of ART Dr Paula Munderi WHO Training Course for Introducing Pharmacovigilance of HIV Medicines 23 - 28 November 2009, Dar Es Salaam.
214 views
Bayer Molecular Customer HIV-1 Quantitation QA Scheme.
212 views
January 19, 2012 10 – 11:30 CHN Headquarters HIV QI Committee.
216 views
1 SWIFT Study: Switching From Lamivudine/Abacavir (3TC/ABC) to Emtricitabine/Tenofovir DF (FTC/TDF) R Campo 1, E DeJesus 2, H Khanlou 3, H Wang 4, K White.
216 views